Vcanbio Cell & Gene Engineering Corp., Ltd (SHA:600645)
China · Delayed Price · Currency is CNY 17.78
-0.24 (-1.33%)
Sep 11, 2026, 3:00 PM CST
SHA:600645 Market Cap
SHA:600645 has a market cap or net worth of 8.11 billion as of September 11, 2026. Its market cap has decreased by -28.71% in one year.
Market Cap
8.11B
Enterprise Value
6.40B
Revenue
1.40B
Ranking
n/a
PE Ratio
71.04
Stock Price
17.78
ChartMarket Cap Chart
Since May 9, 2006, SHA:600645's market cap has increased from 610.06M to 8.11B, an increase of 1,228.69%. That is a compound annual growth rate of 13.55%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 11, 2026 | 8.11B | -29.44% |
| Dec 31, 2025 | 11.49B | 30.57% |
| Dec 31, 2024 | 8.80B | -7.24% |
| Dec 29, 2023 | 9.49B | 19.17% |
| Dec 30, 2022 | 7.96B | -32.61% |
| Dec 31, 2021 | 11.81B | 28.71% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Shanghai OPM Biosciences | 9.31B |
| Jiangsu Sinopep-Allsino Biopharmaceutical | 9.09B |
| Liaoning Chengda Biotechnology | 8.36B |
| Chongqing Genrix Biopharmaceutical | 8.20B |
| Chengdu Easton Biopharmaceuticals | 8.08B |
| Aurisco Pharmaceutical | 7.75B |
| Beijing Hotgen Biotech | 7.72B |
| Daan Gene | 7.59B |